Ratings by TD Cowen (Tyler Van Buren)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/23/2026 | Apogee Therapeutics Inc | APGE | Downgrade | Hold (Buy) |
132.55 (132.93) |
0.29% | Details | |
| 6/2/2026 | Odyssey Therapeutics | ODTX | New Coverage | Buy (N/A) |
16.96 (18.57) |
9.49% | Details | |
| 5/5/2026 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2026 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2026 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 4/7/2026 | Soleno Therapeutics Inc. | SLNO | Downgrade | Hold (Buy) |
39.49 (53.01) |
34.24% | Details | |
| 3/27/2026 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2026 | Maze Therapeutics | MAZE | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2026 | MBX Biosciences Inc | MBX | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2026 | Biohaven Pharma | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Jade Biosciences | JBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | Arcellx Inc. | ACLX | Downgrade | Hold (Buy) |
113.79 (115.07) |
1.12% | Details | |
| 2/26/2026 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | Soleno Therapeutics Inc. | SLNO | Maintain | (N/A) |
|
Details | ||
| 2/26/2026 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | (N/A) |
|
Details | ||
| 2/20/2026 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2026 | CRISPR Therapeutics | CRSP | Maintain | (N/A) |
|
Details | ||
| 2/12/2026 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2026 | Akoustis Technologies | AKTS | New Coverage | Buy (N/A) |
21.98 (28.52) |
29.75% | Details | |
| 1/29/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2026 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 1/12/2026 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2025 | C4 Therapeutics | CCCC | New Coverage | Buy (N/A) |
2.54 (4.26) |
67.72% | Details | |
| 11/5/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2025 | MBX Biosciences Inc | MBX | New Coverage | Buy (N/A) |
20.61 (48.99) |
137.7% | Details | |
| 10/31/2025 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | BridgeBio Pharma | BBIO | Maintain | (N/A) |
|
Details | ||
| 10/30/2025 | BridgeBio Pharma | BBIO | Maintain | (N/A) |
|
Details | ||
| 10/29/2025 | Regeneron Pharma | REGN | Maintain | (N/A) |
|
Details | ||
| 10/28/2025 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2025 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2025 | Summit Therapeutics plc | SMMT | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2025 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 8/1/2025 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 8/1/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2025 | Ideaya Biosciences | IDYA | New Coverage | Buy (N/A) |
21.81 (37.13) |
70.24% | Details | |
| 7/3/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2025 | Soleno Therapeutics Inc. | SLNO | New Coverage | Buy (N/A) |
79.98 (39.49) |
-50.63% | Details | |
| 6/11/2025 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2025 | Rocket Pharmaceuticals | RCKT | Downgrade | Hold (Buy) |
6.27 (3.43) |
-45.3% | Details | |
| 5/19/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2025 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2025 | Summit Therapeutics plc | SMMT | Upgrade | Buy (N/A) |
24.29 (14.41) |
-40.68% | Details | |
| 5/2/2025 | Arvinas Inc. | ARVN | Downgrade | Hold (Buy) |
7.23 (8.25) |
14.11% | Details | |
| 5/2/2025 | Jade Biosciences | JBIO | New Coverage | Buy (N/A) |
10.00 (22.42) |
124.2% | Details | |
| 4/23/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2025 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 4/23/2025 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2025 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2025 | Maze Therapeutics | MAZE | New Coverage | Buy (N/A) |
10.82 (26.80) |
147.69% | Details | |
| 2/21/2025 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2025 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2025 | CRISPR Therapeutics | CRSP | Upgrade | Hold (Sell) |
39.62 (54.79) |
38.29% | Details | |
| 2/11/2025 | Crinetics | CRNX | New Coverage | Buy (N/A) |
36.53 (36.77) |
0.66% | Details | |
| 1/29/2025 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 1/29/2025 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2025 | CG Oncology | CGON | New Coverage | Buy (N/A) |
29.72 (70.82) |
138.29% | Details | |
| 12/12/2024 | Keros Therapeutics | KROS | Downgrade | Hold (Buy) |
68.65 (11.17) |
-83.73% | Details | |
| 12/9/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2024 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2024 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2024 | Fate Therapeutics | FATE | Maintain | Hold (N/A) |
|
Details | ||
| 11/14/2024 | Acelyrin Inc | SLRN | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2024 | Kronos Bio Inc. | KRON | Downgrade | Hold (Buy) |
0.92 (0.88) |
-4.35% | Details | |
| 11/13/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2024 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 11/6/2024 | CRISPR Therapeutics | CRSP | Maintain | Sell (N/A) |
|
Details | ||
| 11/4/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2024 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2024 | Tyra Biosciences | TYRA | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2024 | Gilead Sciences | GILD | Maintain | Buy (Buy) |
|
Details | ||
| 10/21/2024 | Moderna | MRNA | Maintain | Hold (Hold) |
|
Details | ||
| 10/18/2024 | Gilead Sciences | GILD | Maintain | Buy (Buy) |
|
Details | ||
| 10/14/2024 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2024 | Bicara Therapeutics Inc | BCAX | New Coverage | Buy (N/A) |
24.45 (25.93) |
6.05% | Details | |
| 10/1/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2024 | Regeneron Pharma | REGN | Maintain | Buy (Buy) |
|
Details | ||
| 9/27/2024 | Regeneron Pharma | REGN | Maintain | Buy (Buy) |
|
Details | ||
| 9/27/2024 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2024 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2024 | Tectonic Therapeutics Inc. | TECX | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2024 | Tectonic Therapeutics Inc. | TECX | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Immunome Inc. | IMNM | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Immunocore Holdings | IMCR | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Oruka Therapeutics | ORKA | New Coverage | Buy (N/A) |
24.89 (83.95) |
237.28% | Details | |
| 9/13/2024 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 9/11/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | Artiva Biotherapeutics | ARTV | Maintain | Buy (N/A) |
|
Details | ||
| 8/30/2024 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2024 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2024 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Fate Therapeutics | FATE | Maintain | Hold (N/A) |
|
Details | ||
| 8/14/2024 | Acelyrin Inc | SLRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Immunome Inc. | IMNM | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Cargo Therapeutics | CRGX | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Artiva Biotherapeutics | ARTV | New Coverage | Buy (N/A) |
11.22 (9.66) |
-13.9% | Details | |
| 8/6/2024 | CRISPR Therapeutics | CRSP | Maintain | Sell (N/A) |
|
Details | ||
| 8/6/2024 | Cartesian Therapeutics | RNAC | New Coverage | Buy (N/A) |
13.98 (10.04) |
-28.18% | Details | |
| 7/23/2024 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2024 | CRISPR Therapeutics | CRSP | Maintain | Sell (N/A) |
|
Details | ||
| 7/23/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2024 | Tyra Biosciences | TYRA | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2024 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 6/25/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2024 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2024 | Tectonic Therapeutics Inc. | TECX | New Coverage | Buy (N/A) |
17.01 (31.04) |
82.48% | Details | |
| 6/14/2024 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 6/14/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2024 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2024 | Immunocore Holdings | IMCR | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2024 | NewAmsterdam Pharma Co NV | NAMS | New Coverage | Buy (N/A) |
20.50 (32.78) |
59.9% | Details | |
| 4/24/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | Immunocore Holdings | IMCR | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2024 | Moderna | MRNA | Maintain | Hold () |
|
Details | ||
| 2/7/2024 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 1/25/2024 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/25/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2024 | Immunome Inc. | IMNM | New Coverage | Buy (N/A) |
11.81 (19.65) |
66.38% | Details | |
| 12/11/2023 | CRISPR Therapeutics | CRSP | Downgrade | Sell (Hold) |
64.54 (39.62) |
-38.61% | Details | |
| 12/6/2023 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2023 | Cargo Therapeutics | CRGX | New Coverage | Buy (N/A) |
15.64 (4.47) |
-71.42% | Details | |
| 11/29/2023 | Spyre | SYRE | New Coverage | Buy (N/A) |
14.50 (85.47) |
489.45% | Details | |
| 11/3/2023 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 11/3/2023 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2023 | Arcellx Inc. | ACLX | New Coverage | Buy (N/A) |
31.75 (113.79) |
258.39% | Details | |
| 10/10/2023 | Mirati Therapeutics | MRTX | Downgrade | Hold (Buy) |
57.02 (58.70) |
2.95% | Details | |
| 8/8/2023 | Apogee Therapeutics Inc | APGE | New Coverage | Buy (N/A) |
20.50 (132.93) |
548.44% | Details | |
| 8/4/2023 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2023 | Moderna | MRNA | Downgrade | Hold (Buy) |
109.95 (61.56) |
-44.01% | Details | |
| 8/1/2023 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2023 | Reata Pharmaceuticals | RETA | Downgrade | Hold (Buy) |
167.19 (172.36) |
3.09% | Details | |
| 7/24/2023 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2023 | Reata Pharmaceuticals | RETA | New Coverage | Buy (N/A) |
103.90 (172.36) |
65.89% | Details | |
| 5/30/2023 | Acelyrin Inc | SLRN | New Coverage | Buy (N/A) |
19.27 (2.27) |
-88.22% | Details | |
| 5/22/2023 | Travere Therapeutics | TVTX | New Coverage | Buy (N/A) |
16.45 (56.68) |
244.56% | Details | |
| 3/13/2023 | Moderna | MRNA | Upgrade | Buy (Hold) |
138.29 (109.95) |
-20.49% | Details | |
| 2/14/2023 | Keros Therapeutics | KROS | New Coverage | Buy (N/A) |
53.02 (68.65) |
29.48% | Details | |
| 2/10/2023 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2023 | BridgeBio Pharma | BBIO | New Coverage | Buy (N/A) |
10.86 (70.34) |
547.7% | Details | |
| 1/30/2023 | Regeneron Pharma | REGN | Upgrade | Buy (Hold) |
742.83 (623.90) |
-16.01% | Details | |
| 1/25/2023 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 1/25/2023 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 1/6/2023 | Fate Therapeutics | FATE | Downgrade | Hold (Buy) |
11.00 (2.17) |
-80.27% | Details | |
| 12/22/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2022 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Immunocore Holdings | IMCR | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2022 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 10/20/2022 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2022 | Deciphera | DCPH | New Coverage | Buy (N/A) |
14.85 (25.59) |
72.32% | Details | |
| 8/8/2022 | Immunocore Holdings | IMCR | New Coverage | Buy (N/A) |
54.40 (30.08) |
-44.71% | Details | |
| 8/3/2022 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 7/20/2022 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 7/12/2022 | Zentalis Pharmaceuticals | ZNTL | New Coverage | Buy (N/A) |
27.16 (3.81) |
-85.97% | Details | |
| 6/22/2022 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 6/8/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 6/6/2022 | Turning Point Therapeutics Inc. | TPTX | Downgrade | Hold (Buy) |
74.59 (76.01) |
1.9% | Details | |
| 5/4/2022 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 4/20/2022 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 4/18/2022 | Gilead Sciences | GILD | Maintain | Buy (Buy) |
|
Details | ||
| 4/6/2022 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (Buy) |
|
Details | ||
| 3/23/2022 | Moderna | MRNA | Maintain | Buy (Buy) |
|
Details | ||
| 3/7/2022 | Gilead Sciences | GILD | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2022 | Tyra Biosciences | TYRA | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2022 | Turning Point Therapeutics Inc. | TPTX | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2022 | Arvinas Inc. | ARVN | Maintain | Buy (Buy) |
|
Details | ||
| 2/24/2022 | Allogene | ALLO | Maintain | Buy (Buy) |
|
Details | ||
| 2/17/2022 | Arvinas Inc. | ARVN | Maintain | Buy (Buy) |
|
Details | ||
| 2/16/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 2/4/2022 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 1/31/2022 | Moderna | MRNA | Maintain | Hold (Hold) |
|
Details | ||
| 1/27/2022 | Moderna | MRNA | Maintain | Hold (N/A) |
|
Details | ||
| 12/13/2021 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2021 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2021 | Olema Pharmaceuticals | OLMA | New Coverage | Buy (N/A) |
10.47 (11.48) |
9.65% | Details | |
| 12/7/2021 | Iovanace Biotherapeutics | IOVA | New Coverage | Buy (N/A) |
16.55 (4.28) |
-74.14% | Details | |
| 12/7/2021 | Regeneron Pharma | REGN | New Coverage | Hold (N/A) |
635.16 (623.90) |
-1.77% | Details | |
| 12/7/2021 | CRISPR Therapeutics | CRSP | New Coverage | Hold (N/A) |
70.09 (54.79) |
-21.83% | Details | |
| 12/7/2021 | Fate Therapeutics | FATE | New Coverage | Buy (N/A) |
48.00 (2.17) |
-95.48% | Details | |
| 12/7/2021 | Moderna | MRNA | New Coverage | Hold (N/A) |
306.72 (61.56) |
-79.93% | Details | |
| 12/7/2021 | Arvinas Inc. | ARVN | New Coverage | Buy (N/A) |
74.44 (7.23) |
-90.29% | Details | |
| 10/20/2021 | Kronos Bio Inc. | KRON | New Coverage | Buy (N/A) |
16.49 (0.92) |
-94.42% | Details | |
| 10/20/2021 | Rocket Pharmaceuticals | RCKT | New Coverage | Buy (N/A) |
27.59 (6.27) |
-77.27% | Details | |
| 10/20/2021 | Gilead Sciences | GILD | New Coverage | Buy (N/A) |
65.90 (125.71) |
90.76% | Details | |
| 10/20/2021 | Allogene | ALLO | New Coverage | Buy (N/A) |
15.73 (2.09) |
-86.71% | Details | |
| 10/20/2021 | Allogene | ALLO | New Coverage | Buy (N/A) |
15.73 (2.09) |
-86.71% | Details | |
| 10/11/2021 | Tyra Biosciences | TYRA | New Coverage | Buy (N/A) |
16.26 (31.07) |
91.08% | Details |
